FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310596537> ?p ?o ?g. }

• W4310596537 endingPage "538" @default.
• W4310596537 startingPage "531" @default.
• W4310596537 abstract "Although human urinary aniline and 2,6-dimethylaniline were unexpectedly detected in biomonitoring data, little is known about the daily intake doses of aniline and 2,6-dimethylaniline in the living environment or their relation to tolerable daily intake (TDI) values in humans. In the current study, to evaluate the daily oral intake of aniline and 2,6-dimethylaniline in humans, forward and reverse dosimetry was carried out using simplified in silico physiologically based pharmacokinetic (PBPK) modeling established using in vivo experimental pharmacokinetic data. These data were from humanized-liver mice after single oral doses of 100 mg/kg aniline (previously determined) and 116 mg/kg 2,6-dimethylanine (currently investigated). The in vivo elimination rates of 2,6-dimethylaniline from plasma in humanized-liver mice were generally slow compared with those of aniline. Faster in vitro metabolic elimination rates of aniline mediated by liver 9000 × g supernatant fractions from rats than those from humans may suggest the existence of higher first-pass effects in rats than in humanized-liver mice. In silico aniline and 2,6-dimethylaniline concentration curves in human urine after virtual oral administrations were estimated by human PBPK models created with data from humanized-liver mice. Reverse dosimetry analysis using human PBPK models estimated the daily intake of aniline, based on reported human urinary concentrations in biomonitoring data, to be roughly similar to the aniline TDI level. These results suggest that forward and reverse dosimetry using simplified human PBPK models founded on data from humanized-liver mice can be used to evaluate possible higher than expected exposures of aniline and 2,6-dimethylaniline in humans." @default.
• W4310596537 created "2022-12-12" @default.
• W4310596537 creator A5024492796 @default.
• W4310596537 creator A5063924812 @default.
• W4310596537 creator A5072278742 @default.
• W4310596537 creator A5075182452 @default.
• W4310596537 creator A5078922881 @default.
• W4310596537 date "2022-01-01" @default.
• W4310596537 modified "2023-10-14" @default.
• W4310596537 title "Forward and reverse dosimetry for aniline and 2,6-dimethylaniline in humans extrapolated from humanized-liver mouse data using simplified physiologically based pharmacokinetic models" @default.
• W4310596537 cites W2009316291 @default.
• W4310596537 cites W2030291741 @default.
• W4310596537 cites W2034756115 @default.
• W4310596537 cites W2096127677 @default.
• W4310596537 cites W2148770756 @default.
• W4310596537 cites W2150212925 @default.
• W4310596537 cites W2150940716 @default.
• W4310596537 cites W2592678609 @default.
• W4310596537 cites W2791653123 @default.
• W4310596537 cites W2886550777 @default.
• W4310596537 cites W2902759653 @default.
• W4310596537 cites W2911093582 @default.
• W4310596537 cites W2921702122 @default.
• W4310596537 cites W2946039334 @default.
• W4310596537 cites W2965834304 @default.
• W4310596537 cites W3033145421 @default.
• W4310596537 cites W3096973126 @default.
• W4310596537 cites W3103761432 @default.
• W4310596537 cites W3111751289 @default.
• W4310596537 cites W3117662313 @default.
• W4310596537 cites W3177291998 @default.
• W4310596537 cites W3194728106 @default.
• W4310596537 cites W3194742763 @default.
• W4310596537 cites W3195420346 @default.
• W4310596537 cites W3202896336 @default.
• W4310596537 cites W3209669344 @default.
• W4310596537 cites W4200330051 @default.
• W4310596537 cites W4220737223 @default.
• W4310596537 cites W4220887289 @default.
• W4310596537 doi "https://doi.org/10.2131/jts.47.531" @default.
• W4310596537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36450497" @default.
• W4310596537 hasPublicationYear "2022" @default.
• W4310596537 type Work @default.
• W4310596537 citedByCount "0" @default.
• W4310596537 crossrefType "journal-article" @default.
• W4310596537 hasAuthorship W4310596537A5024492796 @default.
• W4310596537 hasAuthorship W4310596537A5063924812 @default.
• W4310596537 hasAuthorship W4310596537A5072278742 @default.
• W4310596537 hasAuthorship W4310596537A5075182452 @default.
• W4310596537 hasAuthorship W4310596537A5078922881 @default.
• W4310596537 hasBestOaLocation W43105965371 @default.
• W4310596537 hasConcept C104317684 @default.
• W4310596537 hasConcept C107872376 @default.
• W4310596537 hasConcept C109051061 @default.
• W4310596537 hasConcept C112705442 @default.
• W4310596537 hasConcept C150903083 @default.
• W4310596537 hasConcept C178790620 @default.
• W4310596537 hasConcept C185592680 @default.
• W4310596537 hasConcept C185867374 @default.
• W4310596537 hasConcept C195289149 @default.
• W4310596537 hasConcept C207001950 @default.
• W4310596537 hasConcept C2775905019 @default.
• W4310596537 hasConcept C2778732584 @default.
• W4310596537 hasConcept C2779244968 @default.
• W4310596537 hasConcept C2910042226 @default.
• W4310596537 hasConcept C2989005 @default.
• W4310596537 hasConcept C33070731 @default.
• W4310596537 hasConcept C55493867 @default.
• W4310596537 hasConcept C71924100 @default.
• W4310596537 hasConcept C75088862 @default.
• W4310596537 hasConcept C86803240 @default.
• W4310596537 hasConcept C98274493 @default.
• W4310596537 hasConceptScore W4310596537C104317684 @default.
• W4310596537 hasConceptScore W4310596537C107872376 @default.
• W4310596537 hasConceptScore W4310596537C109051061 @default.
• W4310596537 hasConceptScore W4310596537C112705442 @default.
• W4310596537 hasConceptScore W4310596537C150903083 @default.
• W4310596537 hasConceptScore W4310596537C178790620 @default.
• W4310596537 hasConceptScore W4310596537C185592680 @default.
• W4310596537 hasConceptScore W4310596537C185867374 @default.
• W4310596537 hasConceptScore W4310596537C195289149 @default.
• W4310596537 hasConceptScore W4310596537C207001950 @default.
• W4310596537 hasConceptScore W4310596537C2775905019 @default.
• W4310596537 hasConceptScore W4310596537C2778732584 @default.
• W4310596537 hasConceptScore W4310596537C2779244968 @default.
• W4310596537 hasConceptScore W4310596537C2910042226 @default.
• W4310596537 hasConceptScore W4310596537C2989005 @default.
• W4310596537 hasConceptScore W4310596537C33070731 @default.
• W4310596537 hasConceptScore W4310596537C55493867 @default.
• W4310596537 hasConceptScore W4310596537C71924100 @default.
• W4310596537 hasConceptScore W4310596537C75088862 @default.
• W4310596537 hasConceptScore W4310596537C86803240 @default.
• W4310596537 hasConceptScore W4310596537C98274493 @default.
• W4310596537 hasIssue "12" @default.
• W4310596537 hasLocation W43105965371 @default.
• W4310596537 hasLocation W43105965372 @default.
• W4310596537 hasOpenAccess W4310596537 @default.
• W4310596537 hasPrimaryLocation W43105965371 @default.

• next